Re-randomization increased recruitment and provided similar treatment estimates as parallel designs in trials of febrile neutropenia.

Journal of Clinical Epidemiology(2018)

引用 5|浏览9
暂无评分
摘要
In the setting of febrile neutropenia, re-randomization increased recruitment whilst providing similar estimates of treatment effect to parallel group trials, with minimal loss-to-follow-up or non-compliance. It appears to be safe and efficient alternative to parallel group designs in this setting.
更多
查看译文
关键词
Re-randomization,Randomized controlled trials,Clinical trials,Febrile neutropenia,Re-enrolment,Poor recruitment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要